We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
1201
CareDx
CDNA
$1.88B
$2.82M ﹤0.01%
266,713
+221,451
+489% +$2.22M
XRT icon
1202
State Street SPDR S&P Retail ETF
XRT
$448M
$2.8M ﹤0.01%
35,476
-4,470
-11% -$326K
CAAP icon
1203
Corporacion America
CAAP
$4.28B
$2.8M ﹤0.01%
166,488
+48,714
+41% +$755K
LSPD icon
1204
Lightspeed Commerce
LSPD
$1.35B
$2.79M ﹤0.01%
198,558
+147,655
+290% +$2.34M
CMCSA icon
1205
CALL
Comcast
CMCSA
$80.9B
$2.78M ﹤0.01%
+70,100
New +$3.02M
SYBT icon
1206
Stock Yards Bancorp
SYBT
$2.43B
$2.77M ﹤0.01%
56,726
-9,959
-15% -$472K
WCN
1207
Waste Connections
WCN
$42.7B
$2.74M ﹤0.01%
15,952
-7,500
-32% -$1.21M
NAMS icon
1208
NewAmsterdam Pharma
NAMS
$3.53B
$2.73M ﹤0.01%
115,380
+81,439
+240% +$1.65M
EFA icon
1209
PUT
iShares MSCI EAFE ETF
EFA
$76.8B
$2.7M ﹤0.01%
+33,300
New +$2.55M
CHD icon
1210
Church & Dwight Co
CHD
$23.4B
$2.69M ﹤0.01%
25,822
-259,616
-91% -$26M
CRM icon
1211
CALL
Salesforce
CRM
$142B
$2.68M ﹤0.01%
9,700
-40,200
-81% -$11.6M
PKX icon
1212
POSCO
PKX
$16.1B
$2.67M ﹤0.01%
34,042
+29,613
+669% +$2.44M
INGN icon
1213
Inogen
INGN
$171M
$2.66M ﹤0.01%
329,312
+243,400
+283% +$1.72M
SLV icon
1214
PUT
iShares Silver Trust
SLV
$28.3B
$2.65M ﹤0.01%
101,300
-184,500
-65% -$3.94M
IGV icon
1215
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$12.2B
$2.62M ﹤0.01%
+32,000
New +$2.7M
BG icon
1216
Bunge Global
BG
$22.8B
$2.62M ﹤0.01%
+25,566
New +$2.39M
CNTA
1217
DELISTED
Centessa Pharmaceuticals
CNTA
$2.62M ﹤0.01%
+231,565
New +$2.19M
OPTU
1218
Optimum Communications Inc
OPTU
$298M
$2.62M ﹤0.01%
1,002,278
-2,904,481
-74% -$7.31M
ICHR icon
1219
Ichor Holdings
ICHR
$2.73B
$2.6M ﹤0.01%
+67,353
New +$2.61M
MLNK
1220
DELISTED
MeridianLink
MLNK
$2.6M ﹤0.01%
+139,042
New +$2.83M
RNAM
1221
DELISTED
Avidity Biosciences
RNAM
$2.6M ﹤0.01%
101,864
-95,852
-48% -$1.5M
FNKO icon
1222
Funko
FNKO
$342M
$2.55M ﹤0.01%
408,609
-594,437
-59% -$4.17M
NOA
1223
North American Construction
NOA
$376M
$2.55M ﹤0.01%
114,303
+18,828
+20% +$438K
CALM icon
1224
Cal-Maine
CALM
$4.2B
$2.54M ﹤0.01%
+43,240
New +$2.46M
FATE icon
1225
Fate Therapeutics
FATE
$283M
$2.54M ﹤0.01%
+345,437
New +$2.14M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.